Skip to main content
Clinical Trials/JPRN-UMIN000023385
JPRN-UMIN000023385
Completed
未知

A prospective cohort study of factors associated with synchronous and metachronous gastric and esophageal cancers after endoscopic submucosal dissection for early gastric cancers - Tohoku GI study

Division of gastroenterology, Tohoku University Graduate School of Medicine0 sites850 target enrollmentAugust 1, 2016

Overview

Phase
未知
Intervention
Not specified
Conditions
Not specified
Sponsor
Division of gastroenterology, Tohoku University Graduate School of Medicine
Enrollment
850
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
August 1, 2016
End Date
December 31, 2024
Last Updated
2 years ago
Study Type
Observational
Sex
All

Investigators

Sponsor
Division of gastroenterology, Tohoku University Graduate School of Medicine

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • (1\) Patients with a history of endoscopic resection for early gastric cancers (2\) Patients with a history or a plan of gastrectomy (3\) Patients with a history or a plan of chemotherapy for gastric cancers (4\) Patients with a history or a plan of surgery, chemotherapy, or radiation therapy for esophageal cancers (5\) Patients with a history of chemotherapy for malignant tumors excluding gastric or esophageal cancers within 5 years (6\) Patients with malignant tumors except for gastric or esophageal cancers who have a plan for endocrine therapy, chemotherapy, or radiation at the time of enrollment (7\) Patients with early gastric cancers which did not meet the curative resection for ESD in the guidelines (8\) Patients with gastric lesions diagnosed as Group 4 in the preoperative diagnosis resulting as no cancer in the pathological diagnosis of ESD specimen (9\) Patients with pregnancy or breast\-feeding (10\) Patients with severe psychiatric disease (11\) Patients regard as inappropriate for enrollment by the researcher (12\) Patients whose serum creatinine level are 2\.0 mg/dL or more (13\) Patients who cannot understand Japanese language

Outcomes

Primary Outcomes

Not specified

Similar Trials